These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1786990

  • 1. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T, Kahl K, Rech K, Bautsch W, Köhl J, Bitter-Suermann D.
    Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990
    [Abstract] [Full Text] [Related]

  • 2. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R, Ambrosius D, Saunders D, Casaretto M, Mittler C, Karwarth G, Görgen S, Bitter-Suermann D.
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human C5a-induced bronchoconstriction in the guinea pig: inhibition by an H1 antagonist after depletion of circulating granulocytes and platelets.
    Fraser DG, Regal JF.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1213-20. PubMed ID: 1684819
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y, Hugli TE.
    J Immunol; 1988 May 15; 140(10):3496-501. PubMed ID: 3283237
    [Abstract] [Full Text] [Related]

  • 5. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
    Huey R, Hugli TE.
    J Immunol; 1985 Sep 15; 135(3):2063-8. PubMed ID: 4020139
    [Abstract] [Full Text] [Related]

  • 7. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S, Ecker U, Hadding U, Bitter-Suermann D.
    J Immunol; 1981 Apr 15; 126(4):1506-9. PubMed ID: 7204973
    [Abstract] [Full Text] [Related]

  • 8. Identification of an antigenic epitope and receptor binding domain of human C5a.
    Johnson RJ, Tamerius JD, Chenoweth DE.
    J Immunol; 1987 Jun 01; 138(11):3856-62. PubMed ID: 2438329
    [Abstract] [Full Text] [Related]

  • 9. Stabilization of C5a receptor--G-protein interactions through ligand binding.
    Wennogle LP, Conder L, Winter C, Braunwalder A, Vlattas S, Kramer R, Cioffi C, Hu SI.
    J Cell Biochem; 1994 Jul 01; 55(3):380-8. PubMed ID: 7962171
    [Abstract] [Full Text] [Related]

  • 10. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P, Grötzinger J, Winkler M, Köhl J, Wollmer A, Klos A, Bautsch W.
    Eur J Biochem; 1994 Feb 01; 219(3):897-904. PubMed ID: 8112341
    [Abstract] [Full Text] [Related]

  • 11. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M, Götze O.
    Immunology; 1994 Aug 01; 82(4):516-21. PubMed ID: 7835913
    [Abstract] [Full Text] [Related]

  • 12. The generation of stable CHO cell lines expressing very high levels of complement C5A receptors and subsequent modulation of binding affinity for C5A.
    Pease JE, Burton DR, Barker MD.
    Biochem Mol Biol Int; 1993 Feb 01; 29(2):339-47. PubMed ID: 8495216
    [Abstract] [Full Text] [Related]

  • 13. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M, Raedt U, Hebell T, Schmidt B, Zimmermann B, Götze O.
    J Immunol; 1993 Oct 01; 151(7):3785-94. PubMed ID: 8376805
    [Abstract] [Full Text] [Related]

  • 14. N-linked glycosylation of the C5a receptor.
    Pease JE, Barker MD.
    Biochem Mol Biol Int; 1993 Nov 01; 31(4):719-26. PubMed ID: 8298500
    [Abstract] [Full Text] [Related]

  • 15. Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex.
    Rollins TE, Siciliano S, Kobayashi S, Cianciarulo DN, Bonilla-Argudo V, Collier K, Springer MS.
    Proc Natl Acad Sci U S A; 1991 Feb 01; 88(3):971-5. PubMed ID: 1899485
    [Abstract] [Full Text] [Related]

  • 16. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
    Van Epps DE, Simpson SJ, Johnson R.
    J Immunol; 1993 Jan 01; 150(1):246-52. PubMed ID: 8417126
    [Abstract] [Full Text] [Related]

  • 17. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B, Rasokat H, Hadding U, Bitter-Suermann D.
    Agents Actions Suppl; 1982 Jan 01; 11():147-57. PubMed ID: 6983827
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets.
    Chen H, Marjan J, Cox AD, Devine DV.
    J Immunol; 1994 Feb 01; 152(3):1332-8. PubMed ID: 8301135
    [Abstract] [Full Text] [Related]

  • 19. Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors.
    Fukuoka Y, Ember JA, Yasui A, Hugli TE.
    Int Immunol; 1998 Mar 01; 10(3):275-83. PubMed ID: 9576615
    [Abstract] [Full Text] [Related]

  • 20. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
    Kawai M, Quincy DA, Lane B, Mollison KW, Or YS, Luly JR, Carter GW.
    J Med Chem; 1992 Jan 24; 35(2):220-3. PubMed ID: 1732540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.